News for hackers. Stuff that matters.
Re:Number of States with High Rates of Adult Obesity More Th... by Beaver117 on Friday September 30, 2022 @03:26PM (#33039547)
Why are we not already using them? Because they're subQ injections? Supply issues? Side effects? They are already proven effective, why is every obese/overweight person not given a script? We could solve the crisis within a year
Re:Number of States with High Rates of Adult Obesity More Th... by bb88 on Friday September 30, 2022 @05:31PM (#33041068)
Before recently most GLP-1 agonists only gave a small amount of weight loss, and they've typically only been approved for type 2 management.

Mounjaro from Eli Lilly though shows great promise with an average weight loss of 50 pounds per participant. It's been approved for type 2 management, but they've also submitted it to the FDA as a weight loss drug.

On the first month on the lowest dose (no exercise), I lost 15 pounds.

The good side is the injection is mostly pain-free, and easy to administer. You will feel a little prick, but it feels mostly like getting a burr stuck to your skin.

The downside is it's $1000/month. Most insurance won't cover it yet. It also makes maybe more sense when insulin costs $5000/year or more. Right now there's a coupon which makes the co-pay $25 but that lasts for only 3 months.

Side effects for me were decreased appetite (which is a good thing), low level nausea, and constipation. All of which were not deal breakers for me.

Re:Number of States with High Rates of Adult Obesity More Th... by akavi on Saturday October 01, 2022 @09:23AM (#33046418)
They're injections, which reduces patient compliance, and they're peptides, which are costly to produce.